Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why CING? Cingulate Inc. Analysis, Price & AI Insights | Whystock

CING

$5.37+0.22 (+4.27%)

Market ClosedLast close May 1

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.